en
Scientific article
Open access
English

Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?

Published inRadiation Oncology, vol. 13, no. 1, 114
Publication date2018
Abstract

This is a dosimetric comparative study intended to establish appropriate low-to-intermediate dose-constraints for the rectal wall (Rwall) in the context of a randomized phase-II trial on urethra-sparing stereotactic body radiotherapy (SBRT) for prostate cancer. The effect of plan optimization on low-to-intermediate Rwall dose and the potential benefit of an endorectal balloon (ERB) are investigated.

Citation (ISO format)
DUBOULOZ, Angèle et al. Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon? In: Radiation Oncology, 2018, vol. 13, n° 1, p. 114. doi: 10.1186/s13014-018-1059-1
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal1748-717X
350views
150downloads

Technical informations

Creation09/13/2018 4:16:00 PM
First validation09/13/2018 4:16:00 PM
Update time03/15/2023 1:51:14 PM
Status update03/15/2023 1:51:13 PM
Last indexation01/17/2024 4:09:20 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack